MarketBeat Instant News Alerts 2 hours agoAcrivon Therapeutics (NASDAQ:ACRV) Given "Sell (E+)" Rating at Weiss RatingsMarketBeatWeiss Ratings reiterated a "sell (e+)" rating on shares of Acrivon Therapeutics in a research report on Wednesday.NASDAQ:ACRVRead Acrivon Therapeutics (NASDAQ:ACRV) Given "Sell (E+)" Rating at Weiss Ratings2 hours agoAcorn Energy's (ACFN) "Buy (B-)" Rating Reiterated at Weiss RatingsMarketBeatWeiss Ratings reaffirmed a "buy (b-)" rating on shares of Acorn Energy in a report on Wednesday.NASDAQ:ACFNRead Acorn Energy's (ACFN) "Buy (B-)" Rating Reiterated at Weiss Ratings2 hours agoACNB (NASDAQ:ACNB) Earns "Hold (C+)" Rating from Weiss RatingsMarketBeatWeiss Ratings reiterated a "hold (c+)" rating on shares of ACNB in a report on Wednesday.NASDAQ:ACNBRead ACNB (NASDAQ:ACNB) Earns "Hold (C+)" Rating from Weiss Ratings2 hours agoACM Research (NASDAQ:ACMR) Receives Hold (C+) Rating from Weiss RatingsMarketBeatWeiss Ratings reiterated a "hold (c+)" rating on shares of ACM Research in a research note on Wednesday.NASDAQ:ACMRRead ACM Research (NASDAQ:ACMR) Receives Hold (C+) Rating from Weiss Ratings2 hours agoACI Worldwide's (ACIW) Hold (C+) Rating Reaffirmed at Weiss RatingsMarketBeatWeiss Ratings reiterated a "hold (c+)" rating on shares of ACI Worldwide in a research report on Wednesday.NASDAQ:ACIWRead ACI Worldwide's (ACIW) Hold (C+) Rating Reaffirmed at Weiss Ratings2 hours agoAchieve Life Sciences' (ACHV) Sell (D-) Rating Reaffirmed at Weiss RatingsMarketBeatWeiss Ratings reaffirmed a "sell (d-)" rating on shares of Achieve Life Sciences in a research report on Wednesday.NASDAQ:ACHVRead Achieve Life Sciences' (ACHV) Sell (D-) Rating Reaffirmed at Weiss Ratings Trending News1Archer Aviation (NYSE:ACHR) Stock Price Up 13.2% - Here's Why2Zacks Research Issues Pessimistic Outlook for NIO Earnings3AST SpaceMobile, Inc. $ASTS Shares Sold by 111 Capital4Meta Platforms (NASDAQ:META) Shares Down 2.3% Following Insider Selling5Kraken Robotics (CVE:PNG) Sets New 12-Month High - What's Next?6MBL Wealth LLC Makes New $591,000 Investment in Solid Power, Inc. $SLDP7Insider Selling: QUALCOMM (NASDAQ:QCOM) CEO Sells 150,000 Shares of Stock8Penny Stocks To Watch Now - October 4th All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Dividend Earnings Earnings Preview Estimates Guidance Insider Trade Lockup Expiration Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoAccuray (NASDAQ:ARAY) Given "Sell (E+)" Rating at Weiss RatingsMarketBeatNASDAQ:ARAYRead Accuray (NASDAQ:ARAY) Given "Sell (E+)" Rating at Weiss Ratings2 hours agoAcadia Healthcare (NASDAQ:ACHC) Given "Sell (D)" Rating at Weiss RatingsMarketBeatNASDAQ:ACHCRead Acadia Healthcare (NASDAQ:ACHC) Given "Sell (D)" Rating at Weiss Ratings2 hours agoAcademy Sports and Outdoors (NASDAQ:ASO) Given Hold (C) Rating at Weiss RatingsMarketBeatNASDAQ:ASORead Academy Sports and Outdoors (NASDAQ:ASO) Given Hold (C) Rating at Weiss Ratings2 hours agoWeiss Ratings Reiterates "Sell (D)" Rating for Acacia Research (NASDAQ:ACTG)MarketBeatNASDAQ:ACTGRead Weiss Ratings Reiterates "Sell (D)" Rating for Acacia Research (NASDAQ:ACTG)2 hours agoAC Immune's (ACIU) "Sell (D-)" Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:ACIURead AC Immune's (ACIU) "Sell (D-)" Rating Reiterated at Weiss Ratings2 hours agoWeiss Ratings Reiterates Sell (E+) Rating for ABVC BioPharma (NASDAQ:ABVC)MarketBeatNASDAQ:ABVCRead Weiss Ratings Reiterates Sell (E+) Rating for ABVC BioPharma (NASDAQ:ABVC)2 hours agoAbsci's (ABSI) Sell (D-) Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:ABSIRead Absci's (ABSI) Sell (D-) Rating Reaffirmed at Weiss Ratings2 hours agoWeiss Ratings Reaffirms "Sell (D-)" Rating for Abivax (NASDAQ:ABVX)MarketBeatNASDAQ:ABVXRead Weiss Ratings Reaffirms "Sell (D-)" Rating for Abivax (NASDAQ:ABVX)2 hours agoAbercrombie & Fitch's (ANF) Hold (C+) Rating Reaffirmed at Weiss RatingsMarketBeatNYSE:ANFRead Abercrombie & Fitch's (ANF) Hold (C+) Rating Reaffirmed at Weiss Ratings2 hours agoAbeona Therapeutics' (ABEO) "Hold (C-)" Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:ABEORead Abeona Therapeutics' (ABEO) "Hold (C-)" Rating Reiterated at Weiss Ratings2 hours agoAbCellera Biologics (NASDAQ:ABCL) Given "Sell (D-)" Rating at Weiss RatingsMarketBeatNASDAQ:ABCLRead AbCellera Biologics (NASDAQ:ABCL) Given "Sell (D-)" Rating at Weiss Ratings2 hours agoAbacus Life's (ABL) "Sell (E+)" Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:ABLRead Abacus Life's (ABL) "Sell (E+)" Rating Reiterated at Weiss Ratings2 hours agoAardvark Therapeutics (NASDAQ:AARD) Receives "Sell (E+)" Rating from Weiss RatingsMarketBeatNASDAQ:AARDRead Aardvark Therapeutics (NASDAQ:AARD) Receives "Sell (E+)" Rating from Weiss Ratings2 hours agoAAON (NASDAQ:AAON) Given "Hold (C)" Rating at Weiss RatingsMarketBeatNASDAQ:AAONRead AAON (NASDAQ:AAON) Given "Hold (C)" Rating at Weiss Ratings2 hours agoA2Z Cust2Mate Solutions (NASDAQ:AZ) Receives Sell (D-) Rating from Weiss RatingsMarketBeatNASDAQ:AZRead A2Z Cust2Mate Solutions (NASDAQ:AZ) Receives Sell (D-) Rating from Weiss Ratings2 hours agoA10 Networks' (ATEN) Hold (C+) Rating Reiterated at Weiss RatingsMarketBeatNYSE:ATENRead A10 Networks' (ATEN) Hold (C+) Rating Reiterated at Weiss Ratings2 hours agoWeiss Ratings Reiterates Hold (C+) Rating for A. O. Smith (NYSE:AOS)MarketBeatNYSE:AOSRead Weiss Ratings Reiterates Hold (C+) Rating for A. O. Smith (NYSE:AOS)2 hours ago908 Devices (NASDAQ:MASS) Receives Sell (D-) Rating from Weiss RatingsMarketBeatNASDAQ:MASSRead 908 Devices (NASDAQ:MASS) Receives Sell (D-) Rating from Weiss Ratings2 hours ago8X8's (EGHT) Sell (D-) Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:EGHTRead 8X8's (EGHT) Sell (D-) Rating Reaffirmed at Weiss Ratings2 hours agoWeiss Ratings Reaffirms "Sell (D-)" Rating for 89BIO (NASDAQ:ETNB)MarketBeatNASDAQ:ETNBRead Weiss Ratings Reaffirms "Sell (D-)" Rating for 89BIO (NASDAQ:ETNB)2 hours ago5E Advanced Materials (NASDAQ:FEAM) Given "Sell (E+)" Rating at Weiss RatingsMarketBeatNASDAQ:FEAMRead 5E Advanced Materials (NASDAQ:FEAM) Given "Sell (E+)" Rating at Weiss Ratings2 hours ago4D Molecular Therapeutics (NASDAQ:FDMT) Given Sell (D-) Rating at Weiss RatingsMarketBeatNASDAQ:FDMTRead 4D Molecular Therapeutics (NASDAQ:FDMT) Given Sell (D-) Rating at Weiss Ratings2 hours ago3D Systems (NYSE:DDD) Earns Sell (D-) Rating from Weiss RatingsMarketBeatNYSE:DDDRead 3D Systems (NYSE:DDD) Earns Sell (D-) Rating from Weiss Ratings2 hours agoWeiss Ratings Reaffirms "Sell (E+)" Rating for 374Water (NASDAQ:SCWO)MarketBeatNASDAQ:SCWORead Weiss Ratings Reaffirms "Sell (E+)" Rating for 374Water (NASDAQ:SCWO) Featured Articles and OffersDatavault AI: The New AI Contender Backed by Big FundingBy Jeffrey Neal Johnson | October 1, 2025Shots officially fired…From Brownstone Research (Ad)General Dynamics Hits New Highs: Why It Might Keep ClimbingBy Jeffrey Neal Johnson | October 2, 2025Top 3 Dividend Achievers for October: High Yields, Growth AheadBy Thomas Hughes | October 1, 20253 Defense Stocks Surging as Ukraine Tensions DeepenBy Dan Schmidt | October 5, 2025Man Who Called Nvidia at $1.10 Says Buy This Now...From The Oxford Club (Ad)Is BigBear.ai the Next Palantir? By Gabriel Osorio-Mazilli | October 3, 2025NVIDIA Breaks Out to New Highs: What Comes Next?By Thomas Hughes | October 2, 2025 Sector NewsAerospace NewsArtificial Intelligence NewsAutomotive NewsConsumer Product NewsEnergy NewsFinancial Services NewsHealthcare NewsIndustrial NewsMedia NewsManufacturing NewsTechnology NewsTransportation NewsRetail News Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
